Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Esophageal Squamous Cell Carcinoma”

104 trials

Showing 20 of 104 results

Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Testing effectiveness (Phase 2)UnknownNCT03579004
What this trial is testing

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsSquamous Cell CarcinomaConcurrent Chemoradiotherapy
Mona Frolova 48
Not applicableNot Yet RecruitingNCT07388095
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 22
Large-scale testing (Phase 3)Looking for participantsNCT04138212
What this trial is testing

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 456
Testing effectiveness (Phase 2)UnknownNCT05828381
What this trial is testing

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Who this might be right for
Immunotherapy;Envafolimab; Esophageal Cancer
Fujian Medical University Union Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT05507411
What this trial is testing

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06663059
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Who this might be right for
Esophageal Cancer
Tang-Du Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06178211
What this trial is testing

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 36
Not applicableActive Not RecruitingNCT06472635
What this trial is testing

A Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study

Who this might be right for
The Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma
Zhejiang University 95
Testing effectiveness (Phase 2)Looking for participantsNCT06869213
What this trial is testing

A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma

Who this might be right for
Esophageal Cancer (EsC)
Peking University Cancer Hospital & Institute 30
Not applicableActive Not RecruitingNCT05951127
What this trial is testing

Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 141
Testing effectiveness (Phase 2)UnknownNCT05323890
What this trial is testing

Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.

Who this might be right for
Advanced Esophageal Squamous Cell Cancer
Shandong Cancer Hospital and Institute 15
Large-scale testing (Phase 3)UnknownNCT05213312
What this trial is testing

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT06952621
What this trial is testing

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 390
Post-approval studies (Phase 4)UnknownNCT05603065
What this trial is testing

Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)

Who this might be right for
Esophageal Squamous Cell Carcinoma
First Affiliated Hospital Xi'an Jiaotong University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06908382
What this trial is testing

Neoadjuvant QL1706 Therapy for ESCC

Who this might be right for
Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shandong Provincial Hospital 32
Testing effectiveness (Phase 2)UnknownNCT05552651
What this trial is testing

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tao Jiang 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06861777
What this trial is testing

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
YIN LI 474
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07191977
What this trial is testing

Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamour Cell Cancer
West China Hospital 41
Testing effectiveness (Phase 2)UnknownNCT04533490
What this trial is testing

A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 42
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation